Artificial Intelligence

Doc at HLTH: I Can’t Imagine Seeing Patients Without AI

A part-time urgent care doctor who runs healthcare and life sciences projects at Anthropic. as well as other AI experts discussed how AI can boost primary carae.

AI has flooded the zone at the annual HLTH conference in Las Vegas. It’s not just the sheer number of AI exhibitors in the designated AI Zone, but also the companies and conversations beyond that spot on the show floor. One such conversation occurred on the “What Should AI Do for Primary Care?” panel on Monday.

Using a Game of Thrones analogy, Dr. Kyu Rhee, president & CEO of the National Association of Community Health Centers, said, “AI has gone through many winters. Winter is always coming with AI. The reality is now there is no more AI winters. AI is here to stay.”

Now that AI is here to stay, the challenge is in “understanding the importance of responsible, equitable, transparent, evidence-based AI,” he said.

presented by

And it appears that as AI can generate evidence quickly, it is attracting physicians. Dr. Sarah Russell is a part-time urgent care doctor at Stanford, spending the rest of her time running healthcare and life sciences projects at Anthropic. On the HLTH panel, she talked about how indispensable AI has become in her practice.

“Funny irony about this, which is when I see patients now, I can’t imagine seeing them without AI,” Russell said.

It’s ironic because patients come to her to get an answer from a clinician but Russell gives and answer and then checks with AI to make sure she is taking into account all of the current medical literature on the subject. She provided an example of a patient who was taking a GLP-1 drug and reported a side effect. The patient wanted to know whether the side effect was tied to the drug she was taking. Russell hadn’t seen that particular side effect of GLP-1s and she asked OpenEvidence to run all the research on side effects of GLP-1s emerging before and after the GLP-1 clinical trials. OpenEvidence provides clinicians with a free AI-powered search platform that gives them answers to medical questions. It also concluded that there was no correlation between the side effect the patient was experiencing and the GLP-1 being consumed.

“I’m able to have a conversation with the patient in which I’m talking about my experience, but also referencing this AI, which I think contributes to trust because I’m saying to the patient, I don’t want to just guess here. I want to ask AI. But there’s a certain irony in the fact that I’m consulting AI in order to take really good care of something,” Russell said.

Where clinicians are turning to AI, consumer technology companies appear to be turning towards the clinician. Take Oura, the maker of a wearable device called Oura Ring whose chief medical officer, Dr. Ricky Bloomfield, was also on the panel at HLTH. Oura helps millions of users track sleep, activity, stress, readiness, women’s health, metabolic health, and heart health. It has 5.7 million paid members. Last week, Oura announced that it is paying $625 million to buy Counsel Health and plans to integrate Counsel Health’s medical AI chatbot and virtual care into its app. In other words, an insight gleaned from the Oura Ring can lead a user to ping Counsel’s medical AI chatbot and that user may ultimately be seen virtually by a licensed Counsel Health doctor delivering care — all within the Oura app. 

If users adopt this model, that will fundamentally alter how people access primary care.

“What we’ve seen is a lot of people are actually stepping away from organized medicine in many ways,” Bloomfield said. “I think it’s accelerated over COVID and they lost trust in the system.”

At this same time, some people decided to take control of their health by buying wearables like the Oura Ring to help them make better decisions about their lives. Before the Counsel Health acquisition, that care delivery piece was handled by someone else. But Oura wanted to be able to be part of delivering the care as well.

“…we feel like we have an obligation if something is going wrong to get them back into healthcare, to get them back in to see a clinician…,” Bloomfield said.

Other than responding to a moral “obligation,” as he seems to suggest, Oura is also responding to market realities: expanding its customer base from the consumer to the employee or covered member necessarily means being more than a point solution and owning more of the care continuum. Counsel Health gives them that capability to approach self-insured employers and payers.

Dr. Rhee of NACHC explained that, especially in community healthcare settings, technology has the opportunity to be an early detector of disease given that many people with underlying symptoms are not seeing doctors, but John Whyte, CEO of the American Medical Association pushed back.

“The challenge is that often patients in community health centers and other areas, they’re not the ones that are wearing what I call smart jewelry — the rings, the watches,” Whyte declared.

Both Whyte and Rhee agreed that technology should help to remove inequities instead of exacerbating them.

Despite the variety of primary needs — from the worried well, to the underserved patient in rural areas to Medicaid patients awaiting cuts to the program — one thing is clear: costs are unsustainable and AI may be just what the doctor ordered.

“There’s a spectrum of needs out there, but we also think that by bringing these technologies together that gives us the opportunity to lower costs as well to make it more accessible, because I don’t think anyone here would disagree that the cost of our healthcare system today are on an unsustainable trajectory,” Bloomfield of Oura said.

Photo: Getty, pagadesign